Pharmacokinetic Comparison Of All FK-506 Formulations

NCT02339246 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Failure

Interventions

DRUG: Prograf vs Envarsus XR vs Astagraf XL
DRUG: Prograf vs Astagraf XL vs Envarsus XR

Sponsor

Veloxis Pharmaceuticals